Orthocell
Share
28/05/2026
Orthocell has been featured in Stockhead, in an article exploring how ASX‑listed medical device companies are progressing in the US market following FDA approvals.
The piece highlights the growing global demand for innovative regenerative medicine solutions and the role Australian companies are playing in advancing patient care.
Read the full article here: https://bit.ly/4f722M2
$OCC hashtag hashtag hashtag hashtag hashtag
21/05/2026
Orthocell CEO Paul Anderson recently joined the ASX Briefs podcast to discuss the Company’s strong commercial momentum and global expansion.
In the episode, Paul shares how Orthocell is entering a high-growth revenue phase, supported by record Q3 FY26 revenue, rapid US adoption of Remplir™ and growing hospital access across key markets.
Orthocell’s regenerative medicine platforms supports the repair of bones, nerves and tendons, and including Remplir™, its breakthrough collagen nerve repair product.
🎧 Listen to the full podcast here: https://open.spotify.com/episode/3sCKlChI4a1xZGzSrC3QUi?si=qj6O8A9ARMORti3gkqdzbg
ORTHOCELL LTD (OCC) - How Remplir Makes Nerve Repair Simpler ASX BRIEFS · Episode
What’s On | Upcoming Events for OCC in Australia
The Orthocell team is looking forward to attending these upcoming events across Australia.
Please drop by to learn more about our suite of Australian-made medical devices spanning nerve, tendon and bone repair.
AusBiotech | Medtech Unlocked�
🗓️ May 19–21, 2026�
📍 Perth
Orthocell Nerve Symposium�
🗓️ June 12�
📍 Sydney
2026 ASPS Plastic Surgery Congress
🗓️ July 24–25�
📍 Brisbane
We look forward to seeing you there.
$OCC
Click here to claim your Sponsored Listing.
Category
Contact the business
Website
Address
Building 191 Murdoch University South Street
Perth, WA
6150
Opening Hours
| Monday | 9am - 5pm |
| Tuesday | 9am - 5pm |
| Wednesday | 9am - 5pm |
| Thursday | 9am - 5pm |
| Friday | 9am - 5pm |
